{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:58:56Z","timestamp":1793480336718,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1245\/s10434-023-14502-3","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T11:02:27Z","timestamp":1699268547000},"page":"1232-1242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype"],"prefix":"10.1245","volume":"31","author":[{"given":"Tao","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Lian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irinel","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pulitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Soubrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas Groot","family":"Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endo","family":"Itaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma Study Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"U.S. Extrahepatic Biliary Malignancy Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"14502_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"14502_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428\u201344.","journal-title":"Lancet."},{"key":"14502_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"14502_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019;71:104\u201314.","journal-title":"J Hepatol."},{"key":"14502_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/bjs\/znac098","volume":"109","author":"T Wei","year":"2022","unstructured":"Wei T, Zhang XF, He J, et al. Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. Br J Surg. 2022;109:610\u20136.","journal-title":"Br J Surg."},{"key":"14502_CR6","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1245\/s10434-021-09811-4","volume":"28","author":"K Sahara","year":"2021","unstructured":"Sahara K, Tsilimigras DI, Toyoda J, et al. Defining the risk of early recurrence following curative-intent resection for distal cholangiocarcinoma. Ann Surg Oncol. 2021;28:4205\u201313.","journal-title":"Ann Surg Oncol."},{"key":"14502_CR7","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00268-018-4530-0","volume":"42","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Beal EW, Chakedis J, et al. Defining early recurrence of hilar cholangiocarcinoma after curative-intent surgery: a multi-institutional study from the US Extrahepatic Biliary Malignancy Consortium. World J Surg. 2018;42:2919\u201329.","journal-title":"World J Surg."},{"key":"14502_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/bjs.10452","volume":"104","author":"K Komaya","year":"2017","unstructured":"Komaya K, Ebata T, Shirai K, et al. Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg. 2017;104:426\u201333.","journal-title":"Br J Surg."},{"key":"14502_CR9","volume-title":"American joint committee on cancer: AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB. American joint committee on cancer: AJCC cancer staging manual. 8th edn. New York: Springer; 2017.","edition":"8"},{"key":"14502_CR10","unstructured":"Board WCoTE. WHO Classification of Tumours, 5th Edition. World Health Organization, 2019; 2019."},{"key":"14502_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jhbp.154","volume":"22","author":"S Aishima","year":"2015","unstructured":"Aishima S, Oda Y. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci. 2015;22:94\u2013100.","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"14502_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.surg.2018.01.001","volume":"163","author":"XF Zhang","year":"2018","unstructured":"Zhang XF, Bagante F, Chen Q, et al. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma. Surgery. 2018;163:1114\u201320.","journal-title":"Surgery."},{"key":"14502_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","volume":"29","author":"Y Nakanuma","year":"2015","unstructured":"Nakanuma Y, Kakuda Y. Pathologic classification of cholangiocarcinoma: New concepts. Best Pract Res Clin Gastroenterol. 2015;29:277\u201393.","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"14502_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H","volume":"38","author":"Y Nakanuma","year":"1997","unstructured":"Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997;38:552\u201370.","journal-title":"Microsc Res Tech."},{"key":"14502_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/PAS.0b013e31802b34b6","volume":"31","author":"S Aishima","year":"2007","unstructured":"Aishima S, Kuroda Y, Nishihara Y, et al. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol. 2007;31:1059\u201367.","journal-title":"Am J Surg Pathol."},{"key":"14502_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","volume":"27","author":"JY Liau","year":"2014","unstructured":"Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Mod Pathol. 2014;27:1163\u201373.","journal-title":"Mod Pathol."},{"key":"14502_CR17","first-page":"351","volume":"60","author":"MS Chen","year":"2022","unstructured":"Chen MS. Thinking and suggestion on the definition, classification and Chinese nomenclature of carcinoma of the bile ducts. Zhonghua Wai Ke Za Zhi. 2022;60:351\u20135.","journal-title":"Zhonghua Wai Ke Za Zhi."},{"key":"14502_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00534-002-0732-8","volume":"10","author":"S Yamasaki","year":"2003","unstructured":"Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10:288\u201391.","journal-title":"J Hepatobiliary Pancreat Surg."},{"issue":"Suppl 1","key":"14502_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39","author":"T Kendall","year":"2019","unstructured":"Kendall T, Verheij J, Gaudio E, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):7\u201318.","journal-title":"Liver Int."},{"key":"14502_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.32624","volume":"77","author":"M Deng","year":"2023","unstructured":"Deng M, Ran P, Chen L, et al. Proteogenomic characterization of cholangiocarcinoma. Hepatology. 2023;77:411\u201329.","journal-title":"Hepatology."},{"key":"14502_CR21","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1245\/s10434-017-5870-y","volume":"24","author":"F Bagante","year":"2017","unstructured":"Bagante F, Spolverato G, Weiss M, et al. Impact of morphological status on long-term outcome among patients undergoing liver surgery for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2017;24:2491\u2013501.","journal-title":"Ann Surg Oncol."},{"key":"14502_CR22","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/hep.25595","volume":"55","author":"M Komuta","year":"2012","unstructured":"Komuta M, Govaere O, Vandecaveye V, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology. 2012;55:1876\u201388.","journal-title":"Hepatology."},{"key":"14502_CR23","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/hep.25587","volume":"55","author":"V Cardinale","year":"2012","unstructured":"Cardinale V, Wang Y, Carpino G, Reid LM, Gaudio E, Alvaro D. Mucin-producing cholangiocarcinoma might derive from biliary tree stem\/progenitor cells located in peribiliary glands. Hepatology. 2012;55:2041\u20132.","journal-title":"Hepatology."},{"key":"14502_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1072-7515(02)01343-1","volume":"195","author":"KS Suh","year":"2002","unstructured":"Suh KS, Chang SH, Lee HJ, Roh HR, Kim SH, Lee KU. Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according to gross morphology. J Am Coll Surg. 2002;195:782\u20139.","journal-title":"J Am Coll Surg."},{"key":"14502_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/PAS.0b013e31820ffdf1","volume":"35","author":"S Aishima","year":"2011","unstructured":"Aishima S, Fujita N, Mano Y, et al. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol. 2011;35:590\u20138.","journal-title":"Am J Surg Pathol."},{"key":"14502_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1365-2559.2012.04316.x","volume":"61","author":"JH Tsai","year":"2012","unstructured":"Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas. Histopathology. 2012;61:1106\u201316.","journal-title":"Histopathology."},{"key":"14502_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2559.2007.02735.x","volume":"51","author":"K Kozaka","year":"2007","unstructured":"Kozaka K, Sasaki M, Fujii T, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: \u201cbile ductular carcinoma.\u201d Histopathology. 2007;51:390\u2013400.","journal-title":"Histopathology."},{"key":"14502_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1309\/AJCP53YVVJCNDZIR","volume":"134","author":"S Aishima","year":"2010","unstructured":"Aishima S, Fujita N, Mano Y, et al. p62+ Hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease. Am J Clin Pathol. 2010;134:457\u201365.","journal-title":"Am J Clin Pathol."},{"key":"14502_CR29","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","volume":"43","author":"BR Kipp","year":"2012","unstructured":"Kipp BR, Voss JS, Kerr SE, et al. Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma. Hum Pathol. 2012;43:1552\u20138.","journal-title":"Hum Pathol."},{"key":"14502_CR30","doi-asserted-by":"publisher","first-page":"e2200065","DOI":"10.1200\/PO.22.00065","volume":"6","author":"F Nichetti","year":"2022","unstructured":"Nichetti F, Niger M. Isocitrate dehydrogenase mutations in cholangiocarcinoma: Still a long road ahead. JCO Precis Oncol. 2022;6:e2200065.","journal-title":"JCO Precis Oncol."},{"key":"14502_CR31","doi-asserted-by":"publisher","first-page":"992606","DOI":"10.3389\/fonc.2022.992606","volume":"12","author":"Z Yu","year":"2022","unstructured":"Yu Z, Ni Q, Jia H, et al. Prognostic analysis of radical resection for iCCA(phl) and iCCA(pps): a retrospective cohort study. Front Oncol. 2022;12:992606.","journal-title":"Front Oncol."},{"key":"14502_CR32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/bjs.8782","volume":"99","author":"ML DeOliveira","year":"2012","unstructured":"DeOliveira ML, Clavien PA. A common language to describe perihilar cholangiocarcinoma. Br J Surg. 2012;99:885\u20136.","journal-title":"Br J Surg."},{"key":"14502_CR33","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14502-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14502-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14502-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T10:23:02Z","timestamp":1704190982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14502-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["14502"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14502-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Guillaume Martel\u2014speaker\u2019s honorarium from Incyte Biosciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}